This $1,559,880 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "PEGASUS: PREGNANCY COMPLICATIONS IN AYA CANCER SURVIVORS" research project at the University of Texas Health Science Center at Houston (UTHealth). The project aims to investigate medical solutions for improved pregnancy outcomes among adolescent and young adult (AYA) cancer survivors, a population at increased risk for pregnancy complications. UTHealth, an experienced recipient of federal grants and contracts, will leverage its expertise in areas such as cancer, cardiovascular health, and women's health to advance this research. The award, with a performance period from April 1, 2025 to March 31, 2029, will enable UTHealth to conduct cutting-edge biomedical and public health research and potentially develop innovative treatments to address these critical challenges faced by AYA cancer survivors.
Generated 3/4/25, 4:07 AM